Prostatype Genomics AB (publ) PROGEN.ST
PROGEN.ST
Prostatype Genomics AB (publ) SPERM.ST
Spermosens AB QLIFE.ST
Qlife Holding AB (publ) EPIS-B.ST
Episurf Medical AB (publ) ODI.ST
ODI Pharma AB APTA.ST
Aptahem AB (publ) AINO.ST
Aino Health AB (publ) FLUI.ST
Fluicell AB (publ) 2CUREX.ST
2cureX AB (publ) CMH.ST
Chordate Medical Holding AB (publ)
Prostatype Genomics AB (publ) SPERM.ST
Spermosens AB QLIFE.ST
Qlife Holding AB (publ) EPIS-B.ST
Episurf Medical AB (publ) ODI.ST
ODI Pharma AB APTA.ST
Aptahem AB (publ) AINO.ST
Aino Health AB (publ) FLUI.ST
Fluicell AB (publ) 2CUREX.ST
2cureX AB (publ) CMH.ST
Chordate Medical Holding AB (publ)
Performance
| Periode | PROGEN.ST | SPERM.ST | QLIFE.ST | EPIS-B.ST | ODI.ST | APTA.ST | AINO.ST | FLUI.ST | 2CUREX.ST | CMH.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -66.38 % | -24.44 % | 5.77 % | -58.54 % | -40.19 % | -24.38 % | 4.52 % | 15.97 % | 158.45 % | -9.11 % |
| YTD | -93.50 % | -48.48 % | 5.77 % | -64.58 % | -48.80 % | -14.93 % | -13.33 % | -37.22 % | 282.50 % | -45.06 % |
| 1Y | -94.84 % | -69.09 % | -9.84 % | -66.04 % | -60.00 % | -18.87 % | 73.33 % | -43.35 % | 175.68 % | -87.43 % |
| 3Y | -99.90 % | -99.82 % | -99.98 % | -97.32 % | -74.40 % | -97.55 % | -10.99 % | -98.57 % | -82.57 % | -98.84 % |
| 5Y | -99.97 % | -99.91 % | -99.99 % | -97.73 % | -74.40 % | -99.30 % | -77.55 % | -99.51 % | -90.10 % | -98.86 % |
| 10Y | -99.97 % | -99.91 % | -99.99 % | -99.56 % | -86.89 % | -99.84 % | -98.27 % | -99.74 % | -79.89 % | -98.86 % |
| From the beginning | -99.97 % | -99.91 % | -99.99 % | -99.28 % | -86.89 % | -99.85 % | -98.27 % | -99.74 % | -79.89 % | -98.86 % |